320
Views
0
CrossRef citations to date
0
Altmetric
Meta Analysis

A systematic review and meta-analysis of the diagnostic effectiveness of human papillomavirus methylation biomarkers for detection of cervical cancer

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 1055-1072 | Received 05 May 2022, Accepted 31 Aug 2022, Published online: 28 Sep 2022

References

  • Arbyn M , WeiderpassE , BruniLet al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health8(2), e191–e203 (2020).
  • Cancer research UK . www.cancerresearchuk.org/about-cancer/cervical-cancer/stages-types-grades/types-and-grades
  • Burd EM . Human papillomavirus and cervical cancer. Clin. Microbiol. Rev.16(1), 1–17 (2003).
  • Rebolj M , RimmerJ , DentonKet al. Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ364, l240 (2019).
  • Braaten KP , LauferMR. Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev Obstet Gynecol.1(1), 2–10 (2008).
  • Chua KL , HjerpeA. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer77, 121–127 (1996).
  • Ho GY , BiermanR , BeardsleyL , ChangCJ , BurkRD. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med.338, 413–428 (1998).
  • Moscicki AB , PalefskyJ , SmithG , SiboshskiS , SchoolnikG. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstst. Gynecol. 82, 578–585 (1993).
  • Ostor AG . Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol.12, 186–192 (1993).
  • Syrjänen KJ . Natural history of genital human papillomavirus infections. In: LaceyCEd. Papillomavirus Reviews (189–206). Leeds University PressLeeds, UK (1996).
  • Shiraz A , CrawfordR , EgawaN , GriffinH , DoorbarJ. The early detection of cervical cancer. The current and changing landscape of cervical disease detection. Cytopathology31(4), 258–270 (2020).
  • Fang J , ZhangH , JinS. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol.35(6), 5083–5093 (2014).
  • Shen S , ZhangS , LiuP , WangJ , DuH. Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer Genet.248–249, 25–30 (2020).
  • Cardoso MFS , CastellettiCHM , Lima-FilhoJL , MartinsDBG , TeixeiraJAC. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles. Mutat. Res. Rev. Mutat. Res.773, 161–173 (2017).
  • Mersakova S , NachajovaM , SzepeP , KasajovaPS , HalasovaE. DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods. Tumour Biol.37(1), 23–27 (2016).
  • Peng L , YuanX , JiangB , TangZ , LiGC. LncRNAs: key players and novel insights into cervical cancer. Tumour Biol.37(3), 2779–2788 (2016).
  • Ivanov MK , TitovSE , DzyubenkoVVet al. Detection of cervical lesions and cancer in air-dried cytologic smears by combined analysis of mRNA and miRNA expression levels. J. Mol. Diagn.23(5), 541–554 (2021).
  • Tornesello ML , BuonaguroL , Giorgi-RossiP , BuonaguroFM. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed. Res. Int.2013, 519619 (2013).
  • Luttmer R , DeStrooper LM , SteenbergenRDet al. Management of high-risk HPV-positive women for detection of cervical (pre)cancer. Expert Rev. Mol. Diagn.16(9), 961–974 (2016).
  • Clarke MA , WentzensenN , MirabelloLet al. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol. Biomarkers Prev.21(12), 2125–2137 (2012).
  • Lorincz AT . Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytol.60(6), 501–512 (2016).
  • Cumpston M , LiT , PageMJet al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev.10, ED000142 (2019).
  • Moher D , LiberatiA , TetzlaffJ , AltmanDG , GroupP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.6(7), e1000097 (2009).
  • Whiting PF , RutjesAW , WestwoodMEet al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med.155(8), 529–536 (2011).
  • Neyeloff JL , FuchsSC , MoreiraLB. Meta-analyses and forest plots using a Microsoft Excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res. Notes5, 52 (2012).
  • Brentnall AR , VasiljevicN , Scibior-BentkowskaDet al. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and EPB41L3 methylation classifier. Cancer Biomark.15(5), 669–675 (2015).
  • Bryant D , HibbittsS , AlmonteM , TristramA , FianderA , PowellN. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women. J. Clin. Virol.66, 66–71 (2015).
  • Bryant D , TristramA , LiloglouT , HibbittsS , FianderA , PowellN. Quantitative measurement of human papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. J. Clin. Virol.59(1), 24–29 (2014).
  • Louvanto K , FrancoEL , RamanakumarAVet al. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int. J. Cancer136(6), E638–645 (2015).
  • Mirabello L , FrimerM , HarariAet al. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. Int. J. Cancer136(4), E146–153 (2015).
  • Mirabello L , SchiffmanM , GhoshAet al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int. J. Cancer132(6), 1412–1422 (2013).
  • Niyazi M , SuiS , ZhuK , WangL , JiaoZ , LuP. Correlation between methylation of human papillomavirus-16 L1 gene and cervical carcinoma in Uyghur women. Gynecol. Obstet. Invest.82(1), 22–29 (2017).
  • Wentzensen N , SunC , GhoshAet al. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J. Natl Cancer Inst.104(22), 1738–1749 (2012).
  • Clarke MA , GradissimoA , SchiffmanMet al. Human papillomavirus DNA methylation as a biomarker for cervical precancer: consistency across 12 genotypes and potential impact on management of HPV-positive women. Clin. Cancer Res.24(9), 2194–2202 (2018).
  • Zhou R , ChenZ , XiaoZR , WangSL , RongC. HPV-related promoter methylation-based gene signature predicts clinical prognosis of patients with cervical cancer. Front. Oncol.11, 753102 (2021).
  • Liu P , IdenM , FyeSet al. Targeted, deep sequencing reveals full methylation profiles of multiple HPV types and potential biomarkers for cervical cancer progression. Cancer Epidemiol. Biomarkers Prev.26(4), 642–650 (2017).
  • Hesselink AT , HeidemanDA , SteenbergenRDet al. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Int. J. Cancer135(4), 880–886 (2014).
  • Lai HC , LinYW , HuangTHet al. Identification of novel DNA methylation markers in cervical cancer. Int. J. Cancer123(1), 161–167 (2008).
  • Koliopoulos G , NyagaVN , SantessoNet al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev.8, CD008587 (2017).
  • Wentzensen N , ShermanME , SchiffmanM , WangSS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol. Oncol.112(2), 293–299 (2009).
  • Kan YY , LiouYL , WangHJet al. PAX1 methylation as a potential biomarker for cervical cancer screening. Int. J. Gynecol. Cancer24(5), 928–934 (2014).
  • Jiang M , XuB , LiXet al. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit. Oncogene38(3), 301–316 (2019).
  • Liu H , MengX , WangJ. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening. Int. J. Gynecol. Cancer30(10), 1488–1492 (2020).
  • Chang CL , HoSC , SuYFet al. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: real-world evidence in Taiwan. Gynecol. Oncol.161(2), 429–435 (2021).
  • Chen Y , CuiZ , XiaoZet al. PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians. Ann. Transl. Med.4(19), 365 (2016).
  • Nikolaidis C , NenaE , PanagopoulouMet al. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis. Cancer Epidemiol.39(5), 682–686 (2015).
  • Kocsis A , TakacsT , JeneyCet al. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int. J. Cancer140(5), 1119–1133 (2017).
  • Jiao X , ZhangS , JiaoJet al. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clin. Epigenetics11(1), 120 (2019).
  • Luttmer R , DeStrooper LM , BerkhofJet al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). Int. J. Cancer138(4), 992–1002 (2016).
  • Salta S , Maia-MocoL , Estevao-PereiraHet al. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: a feasibility study. Int. J. Cancer149(11), 1916–1925 (2021).
  • Del Pino M , SierraA , MarimonLet al. CADM1, MAL, and miR124 promoter methylation as biomarkers of transforming cervical intrapithelial lesions. Int. J. Mol. Sci.20(9), 2262 (2019).
  • Doufekas K , HadwinR , KandimallaRet al. GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer. Int. J. Gynecol. Cancer23(6), 1050–1055 (2013).
  • Lorincz AT . Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev. Mol. Diagn.14(3), 293–305 (2014).
  • Fernandez AF , RosalesC , Lopez-NievaPet al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res.19(3), 438–451 (2009).
  • Lorincz AT , BrentnallAR , VasiljevicNet al. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int. J. Cancer133(3), 637–644 (2013).
  • Banila C , LorinczAT , Scibior-BentkowskaDet al. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: a worldwide study. Int. J. Cancer150(2), 290–302 (2022).
  • Murakami I , FujiiT , DanKet al. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia. J. Clin. Virol.58(1), 149–154 (2013).
  • Hsu YW , HuangRL , SuPHet al. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia. J. Gynecol. Oncol.28(4), e56 (2017).
  • Patel DA , RozekLS , ColacinoJAet al. Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. J. Virol. Methods184(1–2), 84–92 (2012).
  • Cuzick J . Human papillomavirus testing for primary cervical cancer screening. JAMA283(1), 108–109 (2000).
  • Cuzick J , SzarewskiA , TerryGet al. Human papillomavirus testing in primary cervical screening. Lancet345(8964), 1533–1536 (1995).
  • Carreon JD , ShermanME , GuillenDet al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int. J. Gynecol. Pathol.26(4), 441–446 (2007).
  • Shen-Gunther J , WangCM , PoageGMet al. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology. Clin. Epigenetics8, 96 (2016).
  • Gupta A , AhmadMK , MahndiAA , SinghR , PradeepY. Promoter methylation and relative mRNA expression of the p16 gene in cervical cancer in north Indians. Asian Pac. J. Cancer Prev.17(8), 4149–4154 (2016).
  • Carozzi F , CecchiniS , ConfortiniMet al. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer108(2), 119–123 (2006).
  • Sagasta A , CastilloP , SacoAet al. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod. Pathol.29(1), 51–59 (2016).
  • Silveira FA , AlmeidaG , FurtadoYet al. HPV DNA genotyping and methylation of gene p16 INK4A in cervical LSIL. Exp. Mol. Pathol.98(2), 308–311 (2015).
  • Tota JE , BentleyJ , BlakeJet al. Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Prev. Med.98, 15–20 (2017).
  • Verlaat W , SnoekBC , HeidemanDaMet al. Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples. Clin. Cancer Res.24(14), 3456–3464 (2018).
  • Van Den Helder R , Van TrommelNE , Van SplunterAP , Lissenberg-WitteBI , BleekerMCG , SteenbergenRDM. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection. Papillomavirus Res.9, 100193 (2020).
  • Van Den Helder R , SteenbergenRDM , Van SplunterAPet al. HPV and DNA methylation testing in urine for cervical intraepithelial neoplasia and cervical cancer detection. Clin. Cancer Res.28(10), 2061–2068 (2022).
  • Zhang J , YaoT , LinZ , GaoY. Aberrant methylation of MEG3 functions as a potential plasma-based biomarker for cervical cancer. Sci. Rep.7(1), 6271 (2017).
  • Daponte A , MichailG , DaponteAI , DaponteN , ValasoulisG. Urine HPV in the context of genital and cervical cancer screening – an update of current literature. Cancers (Basel)13(7), 1640 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.